FDA to post data on COVID-19 therapeutic, vaccine EUAs

Responding to public criticism of some of its COVID-19 emergency use authorization decisions, as well as a recommendation from a government watchdog agency, FDA announced Tuesday that it will publicly post reviews of the scientific data and information supporting regulatory decisions about EUAs of COVID-19 therapeutics and biologics, including vaccines.

The decision is consistent with a recommendation the Government Accountability Office (GAO) made in a report released Tuesday. ...